» Articles » PMID: 36687527

Digital Pathology Implementation in a Private Laboratory: The CEDAP Experience

Abstract

Introduction: The transition to digital pathology has been carried out by several laboratories across the globe, with some cases described in Portugal. In this article, we describe the transition to digital pathology in a high-volume private laboratory, considering the main challenges and opportunities.

Material And Methods: Our process started in 2020, with laboratory workflow adaptation and we are currently using a high-capacity scanner (Aperio GT450DX) to digitize slides at 20×. The visualization system, Aperio eSlide Manager WebViewer, is integrated into the Laboratory System. The validation process followed the Royal College of Pathologists Guidelines.

Results: Regarding validation, the first phase detected an error rate of 6.8%, mostly due to digitization errors. Phase optimization and collaboration with technical services led to improvements in this process. In the second validation phase, most of the slides had the desired quality for evaluation, with only an error rate of 0.6%, corrected with a new scan. The interpathologist correlation had a total agreement rate of 96.87% and 3.13% partial agreement.

Conclusion: The implementation and validation of digital pathology was a success, being ready for prime time. The total integration of all laboratory systems and the acquisition of new equipment will maximize their use, especially with the application of artificial intelligence algorithms.

Citing Articles

An equivalency and efficiency study for one year digital pathology for clinical routine diagnostics in an accredited tertiary academic center.

Iwuajoku V, Ekici K, Haas A, Khan M, Kazemi A, Kasajima A Virchows Arch. 2025; .

PMID: 39964525 DOI: 10.1007/s00428-025-04043-3.


Understanding the financial aspects of digital pathology: A dynamic customizable return on investment calculator for informed decision-making.

Ardon O, Asa S, Lloyd M, Lujan G, Parwani A, Santa-Rosario J J Pathol Inform. 2024; 15:100376.

PMID: 38736870 PMC: 11087961. DOI: 10.1016/j.jpi.2024.100376.


[Artificial intelligence for pathology-how, where, and why?].

Schuffler P, Steiger K, Mogler C Pathologie (Heidelb). 2024; 45(3):198-202.

PMID: 38472382 PMC: 11045628. DOI: 10.1007/s00292-024-01314-9.


[Digital transformation of a routine histopathology lab : Dos and don'ts!].

Iwuajoku V, Haas A, Ekici K, Khan M, Stogbauer F, Steiger K Pathologie (Heidelb). 2024; 45(2):98-105.

PMID: 38189845 PMC: 10902067. DOI: 10.1007/s00292-023-01291-5.

References
1.
Lancellotti C, Cancian P, Savevski V, Kotha S, Fraggetta F, Graziano P . Artificial Intelligence & Tissue Biomarkers: Advantages, Risks and Perspectives for Pathology. Cells. 2021; 10(4). PMC: 8066881. DOI: 10.3390/cells10040787. View

2.
Wright A, Smith D, Dhurandhar B, Fairley T, Scheiber-Pacht M, Chakraborty S . Digital slide imaging in cervicovaginal cytology: a pilot study. Arch Pathol Lab Med. 2012; 137(5):618-24. DOI: 10.5858/arpa.2012-0430-OA. View

3.
Retamero J, Aneiros-Fernandez J, Del Moral R . Complete Digital Pathology for Routine Histopathology Diagnosis in a Multicenter Hospital Network. Arch Pathol Lab Med. 2019; 144(2):221-228. DOI: 10.5858/arpa.2018-0541-OA. View

4.
Liu Y, Kohlberger T, Norouzi M, Dahl G, Smith J, Mohtashamian A . Artificial Intelligence-Based Breast Cancer Nodal Metastasis Detection: Insights Into the Black Box for Pathologists. Arch Pathol Lab Med. 2018; 143(7):859-868. DOI: 10.5858/arpa.2018-0147-OA. View

5.
Hassell L, Absar S, Chauhan C, Dintzis S, Farver C, Fathima S . Pathology Education Powered by Virtual and Digital Transformation: Now and the Future. Arch Pathol Lab Med. 2022; 147(4):474-491. DOI: 10.5858/arpa.2021-0473-RA. View